Action of tocilizumab on energy expenditure in rheumatoid arthritis: A prospective study using calorimetry and actimetry

Joint Bone Spine. 2017 Dec;84(6):751-752. doi: 10.1016/j.jbspin.2016.11.011. Epub 2016 Dec 23.

Authors

Marie Hugo¹, Audrey Pierreisnard², Nadia Mehsen-Cetre², Henri Gin³, Thierry Schaeverbeke², Vincent Rigalleau³

Affiliations

¹ Nutrition-Diabetology department, CHU Bordeaux, avenue Magellan, 33600 Pessac, France. Electronic address: m.hugo@mspb.com.
² Rheumatology department, CHU Bordeaux, avenue Magellan, 33600 Pessac, France.
³ Nutrition-Diabetology department, CHU Bordeaux, avenue Magellan, 33600 Pessac, France.

PMID: 28017819
DOI: 10.1016/j.jbspin.2016.11.011

No abstract available

Keywords: Energy expenditure; Fat free mass; Interleukin-6; Physical activity; Rheumatoid arthritis; Tocilizumab.

Publication types

Letter

MeSH terms

Actigraphy / methods*
Adult
Antibodies, Monoclonal, Humanized / administration & dosage*
Arthritis, Rheumatoid / diagnosis
Arthritis, Rheumatoid / drug therapy*
Body Composition / drug effects
Calorimetry / methods*
Cohort Studies
Energy Metabolism / drug effects*
Female
Humans
Male
Middle Aged
Prognosis
Prospective Studies
Severity of Illness Index
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
tocilizumab